...
首页> 外文期刊>Surgical innovation >Efficacy of New Polylactic Acid Nonwoven Fabric as a Hemostatic Agent in a Rat Liver Resection Model
【24h】

Efficacy of New Polylactic Acid Nonwoven Fabric as a Hemostatic Agent in a Rat Liver Resection Model

机译:新型聚乳酸非织造织物在大鼠肝切除模型中止血剂的疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Background. During minimally invasive surgery, efficient and nontoxic hemostats are important for difficult to access bleeding areas. Polylactic acid is an ecofriendly hemostatic agent and we aimed to evaluate the efficacy of a polylactic acid nonwoven fabric (PLAF) developed by Toray Industries, Inc, on liver hemostasis in a preclinical study. Materials and Methods. PLAF consists of both 1-mu m diameter fibers and 100-mu m diameter beaded fibers. Four rats were used, and 2 trough-shaped resections of the liver parenchyma were performed (n = 8 lobes). Immediately after the resection, PLAF (PLAF group: n = 4 lobes) or rayon gauze (Rayon group: n = 4 lobes) were applied on the resected plane and compressed manually. We compared the mean time to hemostasis and blood loss per lobe, as well as histological findings between the groups. Results. The PLAF group had a significantly shorter bleeding time (P = .006), and showed lower blood loss compared with the Rayon group (P = .076). Histopathological evaluation showed a large amount of beads on the liver surface in the PLAF group. Aggregated red blood cells evident by electron microscopy and von Willebrand factor immunofluorescence were seen surrounding the beads. The PLAF group showed significantly greater von Willebrand factor expression than the Rayon group (P = .004). Discussion. This new PLAF showed superior outcomes thanks to its unique characteristic of forming beaded nanofibers, and it has the potential to be an efficient hemostat in minimally invasive surgery in the human body.
机译:背景。在微创手术期间,有效和无毒的止血率对于难以进入出血区域很重要。聚乳酸是一种生态厌恶止血剂,旨在评估Toray Industries,Inc,肝脏止血中的聚乳酸无纺布(PLAF)在临床前研究中产生的疗效。材料和方法。 PLAF由1-mu m直径纤维和100μm直径的串珠纤维组成。使用四只大鼠,并进行2个叶片状物的切片(n = 8个叶)。切除后立即,在切除的平面上施加PLAF(PLAF组:N = 4个裂片)或人造纱(人造丝组:N = 4个裂片)并手动压缩。我们将平均时间与每个叶片的平均时间与止血和血液损失相比,以及组之间的组织学结果。结果。 PLAF组的出血时间明显较短(p = .006),与人造丝组相比显示出较低的血液损失(P = .076)。组织病理学评估在PLAF组的肝脏表面上显示大量珠子。围绕珠子看到通过电子显微镜和von Willebrand因子免疫荧光显而易见的聚集红细胞。 PLAF组von Willebrand因子表达明显大于人造丝组(P = .004)。讨论。由于其形成串珠纳米纤维的独特特征,这种新的PLAF显示出优越的结果,并且它具有在人体中微创手术中的有效止血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号